Lung Fung Group Holdings Limited has finalised the offer price for its Hong Kong initial public offering at HK$5.18 per share, the bottom of the indicated range of HK$5.18–6.38. The Global Offering comprises 125 million shares, split into 12.5 million Hong Kong Offer Shares (10%) and 112.5 million International Offer Shares (90%). No over-allotment option was exercised.

The Hong Kong Public Offering attracted 133,189 valid applications and was 664.92 times oversubscribed, while the International Offering was 3.18 times covered by 78 placees. The company issued a high-concentration warning: the top 10 placees will collectively hold 12.47% of the enlarged share capital at listing, and the top 25 shareholders will control 94.32%.

Gross proceeds are expected to reach HK$647.50 million, with estimated listing expenses of HK$47.90 million, resulting in net proceeds of HK$599.60 million. Upon completion, the company will have 500 million shares outstanding, implying a market capitalisation of HK$2.59 billion. Public investors will hold the required 25% free float under Listing Rule 8.08.

Controlling shareholder TTK Holding Limited will own 75.00% of the issued share capital post-listing and is subject to a six-month statutory lock-up ending 4 December 2026, followed by a further six-month period with disposal restrictions until 4 June 2027.

Dealings in Lung Fung Group shares are scheduled to commence on 5 June 2026 at 9:00 a.m. on the Hong Kong Stock Exchange under the stock code 2290, trading in board lots of 500 shares.